VISIT TO EMIRATES FACILITIES
The traffic department of Moehs Group has had the opportunity to visit Emirates facilities at Barcelona Airport where they saw, first hand, how the air
Moehs Group member of CataloniaBio & HealthTech
From Moehs Group we would like to announce our incorporation as a member of the CataloniaBio & HealthTech platform. An entity that represents companies in
CARBON FOOTPRINT CERTIFICATE 2023
We are very proud to share the results obtained on the reduction of our carbon footprint! Once again, at Moehs Group, we continue striving and
INTERMON OXFAM TRAILWALKER SPONSORSHIP
On Sunday 7th April Oxfam Intermon organized the TRAILWALKER walk, the biggest sporting and solidarity challenge that consists of covering 100 km in 32 hours,
PARTICIPATION IN S3 INDUSTRY PROJECT
Moehs Group participates in the S3 Indústria project together with teachers from the Chemistry department of the Institutes Federica Montseny (Burjassot, Valencia) and Dr. Peset
PROJECT NITROSO-SITAGLIPTIN IMPURITY
We are proud to announce that the Moehs Research and Development project regarding nitroso-Sitagliptin impurity has been published by the scientific Journal of Separation Science
CPHI BARCELONA
Moehs Group participated in CPHI Barcelona, the great European event of the pharmaceutical sector. At our stand 6B40 in Hall 6, our team received hundreds
NEW JAPANESE PATENT FOR EDOXABAN
Moehs Group has just received Japanese patent JP7327736 for the API Edoxaban. This document is related to an improving method to produce EDOXABAN allowing us
NITROSAMINES PROJECT
We are proud to announce that Moehs has taken one step further on the nitrosamines project by publishing an article in the scientific Journal of
